These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2259894)

  • 1. B27-transgenic mice and disease.
    Ivanyi P
    Scand J Rheumatol Suppl; 1990; 87():97. PubMed ID: 2259894
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection.
    Nickerson CL; Luthra HS; Savarirayan S; David CS
    Hum Immunol; 1990 Aug; 28(4):382-96. PubMed ID: 2391253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
    Nickerson CL; Hogen KL; Luthra HS; David CS
    Scand J Rheumatol Suppl; 1990; 87():85-90; discussion 90. PubMed ID: 2259892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in Yersinia arthritis.
    Repo H; Meri S; Leirisalo-Repo M
    Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune responses in yersinia-associated reactive arthritis.
    Aho K; Ahvonen P; Juvakoski T; Kousa M; Leirisalo M; Laitinen O
    Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
    Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-microbe interaction in HLA-B27-associated diseases.
    Granfors K
    Ann Med; 1997 Apr; 29(2):153-7. PubMed ID: 9187232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
    Lahesmaa R; Eerola E; Toivanen A
    Ann Rheum Dis; 1992 Jan; 51(1):97-100. PubMed ID: 1531747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
    Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
    Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H; Leirisalo M; Tiilikainen A; Laitinen O
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
    Sheldon PJ; Mair NS; Fox E
    Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
    Leino R; Vuento R; Koskimies S; Viander M; Toivanen A
    Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.
    Merilahti-Palo R; Söderström KO; Lahesmaa-Rantala R; Granfors K; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):87-90. PubMed ID: 1998396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil function and HLA-B27.
    Repo H; Leirisalo M; Koivuranta P; Osterman T; Kiistala U; Gahmberg CG; Vapaatalo H; Tiilikainen A; Laitinen O
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD; Asmussen JU
    Z Rheumatol; 1993; 52(4):210-4. PubMed ID: 8212919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.